Trump-Appointed Judge Backs Illinois Gun and Magazine Ban in 2-1 Ruling
The Seventh Circuit Court of Appeals has upheld Illinois' statewide ban on firearms classified as assault weapons and magazines exceeding 10-round capacity. The panel split 2-1, with Judge Amy St. Eve—a Trump appointee—writing the majority opinion in favor of the restrictions. The decision affirms the state's most aggressive gun control measure since the 2023 passage of the ban.
Key Details
Vote: 2-1 panel decision in favor of the state.
Authoring Judge: Amy St. Eve (appointed by Trump in 2019).
Ban Scope: Covers firearms termed assault weapons and detachable magazines holding more than 10 rounds.
Court Level: Appellate review of the constitutionality of Illinois' enforcement of the ban.
Why It Matters for Gun Owners
This ruling directly affects Illinois residents and sets precedent across the Seventh Circuit's jurisdiction—covering Illinois, Indiana, and Wisconsin. Gun owners in Illinois already face confiscation or mandatory registration of affected firearms. The decision signals that courts may uphold magazine restrictions and rifle bans even when authored by judges appointed under pro-Second Amendment administrations. Owners in nearby states should monitor how this precedent shapes pending challenges to their own restrictions. Compliance deadlines and registration windows vary by locality; Illinois gun owners must confirm current deadlines with their county sheriff's office or state police.
DownRange Analysis
St. Eve's majority opinion is the real story here. Gun owners banking on Trump-appointed judges to strike down magazine caps and rifle bans just lost that assumption. The decision suggests the Bruen framework—which requires laws to align with historical tradition—is producing inconsistent results even among constitutionally minded judges. A dissent likely argued the ban fails historical scrutiny. This ruling will fuel challenges at the Supreme Court level but won't stop Illinois enforcement. Gun owners should assume magazine restrictions survive appellate review and plan purchases and compliance accordingly.
